| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/1995 | WO1995018600A1 Dermatological composition based on crotamiton and at least one cationic antiseptic |
| 07/13/1995 | WO1995018547A1 Method of enhancing the human immune system |
| 07/13/1995 | WO1995018533A1 Methods and compounds affecting adipocyte differentiation and obesity |
| 07/13/1995 | WO1995017154A3 Use of thalidomide for treating neurocognitive disorders |
| 07/13/1995 | WO1995016695A3 3'-aziridino-anthracycline derivatives |
| 07/13/1995 | WO1995008631A3 Target antigens of transmission blocking antibodies for malaria parasites |
| 07/13/1995 | DE4400375A1 An agent for inhibiting sexual transfer of diseases to females |
| 07/13/1995 | CA2181082A1 Oligomeric compounds having nitrogen-containing linkages |
| 07/13/1995 | CA2180651A1 Phenyl heterocycles as cox-2 inhibitors |
| 07/13/1995 | CA2180548A1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 07/13/1995 | CA2180477A1 Curcumin, analogues of curcumin and novel uses thereof |
| 07/13/1995 | CA2180465A1 Method of enhancing the human immune system |
| 07/13/1995 | CA2180446A1 Pharmaceutical compositions |
| 07/13/1995 | CA2180441A1 Bicyclic fibrinogen antagonists |
| 07/13/1995 | CA2180379A1 Novel optionally substituted phenylimidazolidines, intermediates and process for their preparation, their use as drugs and pharmaceutical compositions containing them |
| 07/13/1995 | CA2180360A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | CA2180340A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof |
| 07/13/1995 | CA2180336A1 Hydrazides of phosphorylated carboxylic acids having therapeutic activity |
| 07/13/1995 | CA2180239A1 A method of treating neurogenic inflammation |
| 07/13/1995 | CA2180238A1 Novel heterocyclic compounds |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | CA2180122A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the usethereof as antagonists for the glycine/nmda receptor |
| 07/13/1995 | CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations |
| 07/13/1995 | CA2179913A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 07/13/1995 | CA2157603A1 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl) alanine derivative as antitumor agent |
| 07/13/1995 | CA2157602A1 Novel 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents |
| 07/13/1995 | CA2139391A1 Azepanes and homologs thereof |
| 07/12/1995 | EP0662481A1 Spiro piperidines and homologs promote release of growth hormone |
| 07/12/1995 | EP0662479A2 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 07/12/1995 | EP0662477A1 Heterobicyclic compounds with fungicidal activity |
| 07/12/1995 | EP0662473A1 2-Oxindole derivatives as tyrosine kinase inhibitors |
| 07/12/1995 | EP0662471A2 Naphthalene derivatives with affinity to the receptors of melatonine, process for their preparation and pharmaceutical compositions containing them |
| 07/12/1995 | EP0662327A1 Use of self-incompatability receptor proteins (SLG and SRK) of plants for the treatment of allergic diseases |
| 07/12/1995 | EP0662326A2 Endoparasitical agents containing praziquantel and epsiprantel |
| 07/12/1995 | EP0662325A2 Inhibition of ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 07/12/1995 | EP0662324A1 Use of beta-adrenergic agonists for treating loss of function of striated muscles |
| 07/12/1995 | EP0662322A2 Pharmaceutical composition for controlled release |
| 07/12/1995 | EP0662319A1 Cosmetic and/or dermatologic composition for the treatment of aging containing ceramides, and its use |
| 07/12/1995 | EP0662318A1 Cosmetic and/or dermatological composition containing salicylic acid derivatives and the solubilisation process of these derivatives |
| 07/12/1995 | EP0662157A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity |
| 07/12/1995 | EP0662140A1 Method of enhancing and/or prolonging expression of a gene introduced into a cell |
| 07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |
| 07/12/1995 | EP0662128A1 Methods and compositions for controlling translation of hcv proteins |
| 07/12/1995 | EP0662077A1 Cd27 ligand |
| 07/12/1995 | EP0662076A1 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 07/12/1995 | EP0662075A1 Prostaglandin analog for treating osteoporosis |
| 07/12/1995 | EP0662073A1 Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent |
| 07/12/1995 | EP0662003A1 Oligonucleotide modulation of cell adhesion |
| 07/12/1995 | EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 07/12/1995 | EP0661982A1 Method for antagonizing inositol 1,4,5-triphosphate |
| 07/12/1995 | EP0661979A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation |
| 07/12/1995 | EP0661978A1 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents |
| 07/12/1995 | EP0661977A1 Treatment of colorectal cancer |
| 07/12/1995 | EP0661976A1 Defaunation method |
| 07/12/1995 | EP0661975A1 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
| 07/12/1995 | EP0661974A1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin |
| 07/12/1995 | EP0661973A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/12/1995 | EP0661972A1 Use of spiperone or spiperone derivatives as immunosuppressant agents |
| 07/12/1995 | EP0661971A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| 07/12/1995 | EP0661970A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 07/12/1995 | EP0661969A1 Use of taxol for treating lymphomas and breast cancer |
| 07/12/1995 | EP0661968A1 Pharmaceutical composition containing carbachol and other cholinergic substances |
| 07/12/1995 | EP0661967A1 Combined virustatic antimediator (covam) treatment of common colds |
| 07/12/1995 | EP0661966A1 Ulcer prevention and treatment composition and method |
| 07/12/1995 | EP0661930A1 Viscous liquid xylitol compositions and method for preparing same |
| 07/12/1995 | EP0650378A4 Treatment of physiological conditions with degassed perfluorocarbon liquid. |
| 07/12/1995 | EP0630232A4 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor. |
| 07/12/1995 | EP0573548B1 Neuroprotectant agents |
| 07/12/1995 | EP0526537B1 5-benzyl barbiturate derivatives |
| 07/12/1995 | EP0463139B1 2,13-disubstituted ergolins, their preparation and their use in drugs |
| 07/12/1995 | CN1105030A Erythropoietin analogs |
| 07/12/1995 | CN1105027A New compound, leustroducsin H, its preparation and its therapeutic use |
| 07/12/1995 | CN1105016A Triglycerides |
| 07/12/1995 | CN1104890A Cation-complexed polysacharides |
| 07/12/1995 | CN1104889A Cessation of tobacco use |
| 07/12/1995 | CN1104888A Pharmaceutical composition for preventing or treating arteriosclerosis |
| 07/12/1995 | CN1104887A Process for producing maibaimicin gastric soluble tablet |
| 07/12/1995 | CN1029314C Substituted thiophenoimidazole derivative process for preparing same, pharmaceutical composition containing same and used as gastric acid secretive inhibitor |
| 07/11/1995 | US5432282 Process for preparing 1,4-dihydro-2-amino-3-carboxy-5-cyano-pyridine derivatives |
| 07/11/1995 | US5432202 Use of polyamines as ionic-channel regulating agents |
| 07/11/1995 | US5432201 Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertension |
| 07/11/1995 | US5432200 Method for increasing urinary excretion of electrolytes |
| 07/11/1995 | US5432199 Use of acetyl D-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment |
| 07/11/1995 | US5432196 Anipamil |
| 07/11/1995 | US5432192 Antihistamines |
| 07/11/1995 | US5432191 Allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 07/11/1995 | US5432190 Pharmaceutical compositions containing triazoles and method of treating estrogen-dependent diseases |
| 07/11/1995 | US5432189 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/11/1995 | US5432187 Benzimidazole anthelmintic in the treatment of microsporidial infections |
| 07/11/1995 | US5432185 Haemorheological use of N-alkylated 1,4-dihydropyridine-dicarboxylic acid esters, and some new compounds |
| 07/11/1995 | US5432183 Use of rapamycin prodrugs as immunosuppressant agents |
| 07/11/1995 | US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 07/11/1995 | US5432179 Antiallergens |
| 07/11/1995 | US5432178 Amidinophenol derivatives |
| 07/11/1995 | US5432177 Treatment of psychotic disorders |
| 07/11/1995 | US5432176 Method of retarding the progression of chronic renal failure |
| 07/11/1995 | US5432175 Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof |
| 07/11/1995 | US5432174 Treatment of ocular hypertension |